Miscellaneous Metabolic Disorders
Gene: SLC39A14
Hypermanganesemia with dystonia-2 (HMNDYT2) is an autosomal recessive neurodegenerative disorder characterized predominantly by loss of motor milestones in the first years of life. Affected individuals then develop rapidly progressive abnormal movements, including dystonia, spasticity, bulbar dysfunction, and variable features of parkinsonism, causing loss of ambulation. Cognition may be impaired, but is better preserved than motor function. The disorder results from abnormal accumulation of manganese (Mn), which is toxic to neurons. Chelation therapy, if started early, may provide clinical benefit.
More than 5 unrelated families reported.
Sources: Expert listCreated: 6 Feb 2021, 3:31 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Hypermanganesemia with dystonia 2, MIM# 617013
Publications
Gene: slc39a14 has been classified as Green List (High Evidence).
Gene: slc39a14 has been classified as Green List (High Evidence).
gene: SLC39A14 was added gene: SLC39A14 was added to Miscellaneous Metabolic Disorders. Sources: Expert list Mode of inheritance for gene: SLC39A14 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC39A14 were set to 27231142; 29685658 Phenotypes for gene: SLC39A14 were set to Hypermanganesemia with dystonia 2, MIM# 617013 Review for gene: SLC39A14 was set to GREEN